Tandem Diabetes Care (NASDAQ:TNDM) is scheduled to announce Q3 earnings results on Monday, November 4th, after market close.
The consensus EPS Estimate is -$0.22 (+64.5% Y/Y) and the consensus Revenue Estimate is $89.28M (+93.0% Y/Y).
Over the last 2 years, tndm has beaten EPS estimates 50% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 10 upward revisions and 0 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.